The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety
EuroIntervention 2010;6:498-504.
Ben J. Van den Branden*, MD; Justin G. Luermans, MD, PhD; Martijn C. Post, MD, PhD; Herbert W. Plokker, MD, PhD; Jurriën M. ten Berg, MD, PhD; Maarten J. Suttorp, MD, PhD
Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
Aims: To compare the mid-term efficacy and safety of the bioabsorbable BioSTAR® device with the non-bioabsorbable CardioSEAL® dev